These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35247435)

  • 1. A novel KCNQ2 missense variant in non-syndromic intellectual disability causes mild gain-of-function of Kv7.2 channel.
    Xiong J; Chen S; Chen B; Zhang W; Chen C; Deng X; He F; Zhang C; Yang L; Wang Y; Peng J; Yin F
    Clin Chim Acta; 2022 May; 530():74-80. PubMed ID: 35247435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of KCNQ2 variants causing either benign neonatal epilepsy or developmental and epileptic encephalopathy.
    Goto A; Ishii A; Shibata M; Ihara Y; Cooper EC; Hirose S
    Epilepsia; 2019 Sep; 60(9):1870-1880. PubMed ID: 31418850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and functional assessment of two novel KCNQ2 gain-of-function variants Y141N and G239S and effects of amitriptyline treatment.
    Bayat A; Iavarone S; Miceli F; Jakobsen AV; Johannesen KM; Nikanorova M; Ploski R; Szymanska K; Flamini R; Cooper EC; Weckhuysen S; Taglialatela M; Møller RS
    Neurotherapeutics; 2024 Jan; 21(1):e00296. PubMed ID: 38241158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KCNQ2 R144 variants cause neurodevelopmental disability with language impairment and autistic features without neonatal seizures through a gain-of-function mechanism.
    Miceli F; Millevert C; Soldovieri MV; Mosca I; Ambrosino P; Carotenuto L; Schrader D; Lee HK; Riviello J; Hong W; Risen S; Emrick L; Amin H; Ville D; Edery P; de Bellescize J; Michaud V; Van-Gils J; Goizet C; Willemsen MH; Kleefstra T; Møller RS; Bayat A; Devinsky O; Sands T; Korenke GC; Kluger G; Mefford HC; Brilstra E; Lesca G; Milh M; Cooper EC; Taglialatela M; Weckhuysen S
    EBioMedicine; 2022 Jul; 81():104130. PubMed ID: 35780567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recurrent KCNQ2 pore mutation causing early onset epileptic encephalopathy has a moderate effect on M current but alters subcellular localization of Kv7 channels.
    Abidi A; Devaux JJ; Molinari F; Alcaraz G; Michon FX; Sutera-Sardo J; Becq H; Lacoste C; Altuzarra C; Afenjar A; Mignot C; Doummar D; Isidor B; Guyen SN; Colin E; De La Vaissière S; Haye D; Trauffler A; Badens C; Prieur F; Lesca G; Villard L; Milh M; Aniksztejn L
    Neurobiol Dis; 2015 Aug; 80():80-92. PubMed ID: 26007637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable expressivity of a likely pathogenic variant in KCNQ2 in a three-generation pedigree presenting with intellectual disability with childhood onset seizures.
    Hewson S; Puka K; Mercimek-Mahmutoglu S
    Am J Med Genet A; 2017 Aug; 173(8):2226-2230. PubMed ID: 28602030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic variants in KCNQ2 cause intellectual deficiency without epilepsy: Broadening the phenotypic spectrum of a potassium channelopathy.
    Mary L; Nourisson E; Feger C; Laugel V; Chaigne D; Keren B; Afenjar A; Billette T; Trost D; Cieuta-Walti C; Gerard B; Piton A; Schaefer E
    Am J Med Genet A; 2021 Jun; 185(6):1803-1815. PubMed ID: 33754465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homomeric Kv7.2 current suppression is a common feature in KCNQ2 epileptic encephalopathy.
    Gomis-Pérez C; Urrutia J; Marcé-Grau A; Malo C; López-Laso E; Felipe-Rucián A; Raspall-Chaure M; Macaya A; Villarroel A
    Epilepsia; 2019 Jan; 60(1):139-148. PubMed ID: 30478917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant.
    Millichap JJ; Miceli F; De Maria M; Keator C; Joshi N; Tran B; Soldovieri MV; Ambrosino P; Shashi V; Mikati MA; Cooper EC; Taglialatela M
    Epilepsia; 2017 Jan; 58(1):e10-e15. PubMed ID: 27861786
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Lee IC; Yang JJ; Liou YM; Wong SH
    Cells; 2022 Mar; 11(5):. PubMed ID: 35269516
    [No Abstract]   [Full Text] [Related]  

  • 11. Nine patients with KCNQ2-related neonatal seizures and functional studies of two missense variants.
    Chokvithaya S; Caengprasath N; Buasong A; Jantasuwan S; Santawong K; Leela-Adisorn N; Tongkobpetch S; Ittiwut C; Saengow VE; Kamolvisit W; Boonsimma P; Bongsebandhu-Phubhakdi S; Shotelersuk V
    Sci Rep; 2023 Feb; 13(1):3328. PubMed ID: 36849527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel homozygous KCNQ3 loss-of-function variant causes non-syndromic intellectual disability and neonatal-onset pharmacodependent epilepsy.
    Lauritano A; Moutton S; Longobardi E; Tran Mau-Them F; Laudati G; Nappi P; Soldovieri MV; Ambrosino P; Cataldi M; Jouan T; Lehalle D; Maurey H; Philippe C; Miceli F; Vitobello A; Taglialatela M
    Epilepsia Open; 2019 Sep; 4(3):464-475. PubMed ID: 31440727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retigabine, a Kv7.2/Kv7.3-Channel Opener, Attenuates Drug-Induced Seizures in Knock-In Mice Harboring Kcnq2 Mutations.
    Ihara Y; Tomonoh Y; Deshimaru M; Zhang B; Uchida T; Ishii A; Hirose S
    PLoS One; 2016; 11(2):e0150095. PubMed ID: 26910900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epileptic Encephalopathy In A Patient With A Novel Variant In The Kv7.2 S2 Transmembrane Segment: Clinical, Genetic, and Functional Features.
    Soldovieri MV; Ambrosino P; Mosca I; Miceli F; Franco C; Canzoniero LMT; Kline-Fath B; Cooper EC; Venkatesan C; Taglialatela M
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel KCNQ2 missense variant expands the genotype spectrum of DEE7.
    Wang C; Zhai J; Chen Y
    Neurol Sci; 2024 Nov; 45(11):5481-5488. PubMed ID: 38880853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human
    Wei AD; Wakenight P; Zwingman TA; Bard AM; Sahai N; Willemsen MH; Schelhaas HJ; Stegmann APA; Verhoeven JS; de Man SA; Wessels MW; Kleefstra T; Shinde DN; Helbig KL; Basinger A; Wagner VF; Rodriguez-Buritica D; Bryant E; Millichap JJ; Millen KJ; Dobyns WB; Ramirez JM; Kalume FK
    J Neurophysiol; 2022 Jul; 128(1):40-61. PubMed ID: 35583973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KCNQ2 encephalopathy: A case due to a de novo deletion.
    Spagnoli C; Salerno GG; Iodice A; Frattini D; Pisani F; Fusco C
    Brain Dev; 2018 Jan; 40(1):65-68. PubMed ID: 28728838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-limited alterations in cortical activity of a knock-in mouse model of KCNQ2-related developmental and epileptic encephalopathy.
    Biba-Maazou N; Becq H; Pallesi-Pocachard E; Sarno S; Granjeaud S; Montheil A; Kurz M; Villard L; Milh M; Santini PL; Aniksztejn L
    J Physiol; 2022 May; 600(10):2429-2460. PubMed ID: 35389519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes.
    Mosca I; Rivolta I; Labalme A; Ambrosino P; Castellotti B; Gellera C; Granata T; Freri E; Binda A; Lesca G; DiFrancesco JC; Soldovieri MV; Taglialatela M
    Front Pharmacol; 2022; 13():872645. PubMed ID: 35770094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced axonal surface expression and phosphoinositide sensitivity in K
    Kim EC; Zhang J; Pang W; Wang S; Lee KY; Cavaretta JP; Walters J; Procko E; Tsai NP; Chung HJ
    Neurobiol Dis; 2018 Oct; 118():76-93. PubMed ID: 30008368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.